| scholarly article | Q13442814 |
| P356 | DOI | 10.1023/A:1012156502624 |
| P698 | PubMed publication ID | 9453074 |
| P2093 | author name string | Z Liang | |
| N D Eddington | |||
| K T Muir | |||
| J E Moreton | |||
| J F Hoke | |||
| S H Haidar | |||
| P2860 | cites work | Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil. | Q51599988 |
| Determination of remifentanil in human blood by liquid-liquid extraction and capillary GC-HRMS-SIM using a deuterated internal standard. | Q51642372 | ||
| Single versus multiple infusions of fentanyl analogues in a rat EEG model. | Q51646256 | ||
| Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. | Q51652742 | ||
| Pharmacodynamics and onset of action of esmolol in anesthetized dogs. | Q51808996 | ||
| Pharmacology and pharmacokinetics of esmolol. | Q51813185 | ||
| Pharmacology of ASL-8052, a Novel β-Adrenergic Receptor Antagonist with an Ultrashort Duration of Action | Q51853180 | ||
| Effects of High-dose Fentanyl Anesthesia on the Electroencephalogram | Q51865995 | ||
| Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods. | Q52712943 | ||
| Biochemical properties of blood esmolol esterase | Q69868226 | ||
| Species differences in the stereoselective hydrolysis of esmolol by blood esterases | Q69922841 | ||
| Forecasting individual pharmacokinetics | Q28244326 | ||
| Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models | Q34276559 | ||
| General anesthetic techniques. | Q41052701 | ||
| Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil | Q41133439 | ||
| Bayesian approaches in pharmacokinetic decision making. | Q41420704 | ||
| EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil | Q43963363 | ||
| Pharmacokinetics, Pharmacodynamics, and Rational Opioid Selection | Q44335933 | ||
| The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers | Q44336344 | ||
| Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). | Q44338196 | ||
| Effects of remifentanil, a new short-acting opioid, on cerebral blood flow, brain electrical activity, and intracranial pressure in dogs anesthetized with isoflurane and nitrous oxide. | Q44339578 | ||
| Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers | Q46533023 | ||
| Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. | Q51574917 | ||
| P433 | issue | 12 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 1817-1823 | |
| P577 | publication date | 1997-12-01 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | The pharmacokinetics and electroencephalogram response of remifentanil alone and in combination with esmolol in the rat. | |
| P478 | volume | 14 |
| Q49548570 | Analysis of species-dependent hydrolysis and protein binding of esmolol enantiomers |
| Q36501060 | Closed-loop continuous infusions of etomidate and etomidate analogs in rats: a comparative study of dosing and the impact on adrenocortical function |
| Q51414149 | Determination of remifentanil in human heparinised whole blood by tandem mass spectrometry with short-column separation. |
| Q37696435 | Possible indications of beta-blockers in the perioperative period other than prevention of cardiac ischemia |
| Q44367432 | Variability of drug self-administration in rats |
Search more.